ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
19 Sep 2018 ESMO 2018 Awardees announced [ESMO Press Release]
10 Sep 2018 Following the tumour DNA trail to crack the secrets of personalised medicine [MAP Press Release] Pathology/Molecular biology - Translational research - Personalised medicine
28 Aug 2018 Men and women are different: Why medical oncology needs to restate the obvious [ESMO Press Release] Diagnosis, Imaging and Staging - Epidemiology/Etiology/Cancer Prevention - Personalised medicine
21 Aug 2018 New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicines [ESMO Press Release] Personalised medicine
05 Jul 2018 ESMO and ASCO call on governments to improve cancer services and reduce cancer deaths [ESMO Press release] Bioethics, legal and economic issues - Epidemiology/Etiology/Cancer Prevention
28 Jun 2018 MAP Congress 2018: Interpreting Molecular Alterations for Clinical Practice Personalised medicine
15 Jun 2018 20 Years of Excellence in Gastrointestinal Research and Practice [WCGI Media Alert] Gastrointestinal cancers
14 Jun 2018 ESMO 2020 Annual Congress back in Madrid
29 May 2018 Man Against Machine: Artificial Intelligence is Better than Dermatologists at Diagnosing Skin Cancer [Annals of Oncology Press Release] Melanoma and other skin tumours - Diagnosis, Imaging and Staging - Epidemiology/Etiology/Cancer Prevention
28 May 2018 ESMO 2018 Congress: Securing Access to Optimal Cancer Care [ESMO Media Alert]
24 May 2018 ESMO Emphasises Importance of Cancer on the Global Health Agenda at the 71st World Health Assembly [ESMO Press Release] Bioethics, legal and economic issues - Epidemiology/Etiology/Cancer Prevention
26 Apr 2018 Quality Cancer Care: Not Just a Matter of Anti-cancer Medicines [Press Statement] Bioethics, legal and economic issues
12 Apr 2018 Coordinating Nurses can Improve Cancer Patients’ Quality of Life and Satisfaction During Treatment [ELCC 2018 Press Release] Lung and other thoracic tumours
12 Apr 2018 Alectinib Provides Longer Symptom Improvement than Crizotinib in ALK-positive Lung Cancer [ELCC 2018 Press Release] Lung and other thoracic tumours
12 Apr 2018 Further Evidence that Immunotherapy Provides a Long-term Survival Benefit for Lung Cancer Patients [ELCC 2018 Press Release] Lung and other thoracic tumours - Cancer Immunology and Immunotherapy